News
40mon MSN
The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
18h
Verywell Health on MSNDaily GLP-1 Pill Shows Promise for Diabetes and Weight Loss, Eli Lilly SaysA new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FACES, talks with Michael See, MS, CDCES, ACSM-CEP, NBC-HWC, about tips for exercise for people living with diabetes. Weiner: ...
Adults with obesity who used medication and received guidance on resistance training and nutrition lost substantially more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results